Life Sciences
Bambusa Therapeutics Raises $168.9 Million in Boston Biotech IPO
The dermatology and autoimmune drug developer priced its upsized offering at the middle of the $15-to-$17 range it had marketed.
Bambusa Therapeutics Inc.
Life Sciences
The dermatology and autoimmune drug developer priced its upsized offering at the middle of the $15-to-$17 range it had marketed.